Stock comparison
Harmony Biosciences Holdings
HRMY
Market cap
$1.75B
Sector
Healthcare
Overall winner
Harmony Biosciences Holdings
HRMY 7–0 PCVX
Vaxcyte
PCVX
Market cap
$6.83B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
HRMYvsPCVX
67B
15F
60C
46D
75B
36D
62C
11F
28F
0F
62C
25F
67B
30F
Side-by-side metrics
| Metric | HRMY | PCVX |
|---|---|---|
| Market cap | $1.75B | $6.83B |
| P/E (TTM) | 11.8x | - |
| EV/EBIT | 6.4x | - |
| ROIC (TTM) | 12.5% | -34.98% |
| Gross margin | 76.55% | 0.0% |
| Net margin | 16.2% | 0.0% |
| Revenue CAGR 5y | 29.85% | - |
| EPS CAGR 5y | 46.45% | - |
| Debt / Equity | 0.2x | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
- ROIC (TTM)12.5%vs -34.98%+136%
- Gross margin76.55%vs 0.0%+100%
- Net margin16.2%vs 0.0%+100%
PCVX leads on
- EV/EBIT-vs 6.4x+180%
- P/E (TTM)-vs 11.8x+165%
- Debt / Equity0.0xvs 0.2x+83%
- Market cap$6.83Bvs $1.75B+74%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.